Replies to post #202065 on Biotech Values

[DewDiligence]

SGNT acquired by Japan’s Nichi-Iko Pharma for $21.75/sh in cash—a 40% premium to Friday’s closing price:

http://finance.yahoo.com/news/nichi-iko-pharmaceutical-co-ltd-063000449.html

The nominal deal value is $736M.